Valganciclovir in the prevention of cytomegalovirus following allogeneic stem cell transplantation.

被引：0
|
作者：
Magalhaes-Silverma, Margarida [1 ]
Parrott, Karen [1 ]
Carter, Thomas [1 ]
Leopold, Christina [1 ]
Raymond, Hohl [1 ]
Roger, Gingrich [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2851.2851
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2851
引用
收藏
页码：807A / 807A
页数：1
相关论文
共 50 条
  • [21] High rate of EBV reactivation following allogeneic stem cell transplantation.
    Hebart, H
    Ott, M
    Wagner, S
    Knecht, H
    MullerKarls, N
    Muller, CA
    Kanz, L
    Einsele, H
    [J]. BLOOD, 1996, 88 (10) : 1697 - 1697
  • [22] Incidence of herpesvirus infections following nonmyeloablative allogeneic stem cell transplantation.
    Junghanss, C
    Boeckh, M
    Carter, R
    Sandmaier, BM
    Maloney, D
    Chauncey, T
    McSweeney, PA
    Corey, L
    Storb, R
    [J]. BLOOD, 2000, 96 (11) : 188A - 188A
  • [23] Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients
    Pastore, D.
    Carluccio, P.
    Gaudio, F.
    Perrone, T.
    Delia, M.
    Albano, F.
    Manduzio, P.
    Fesce, V.
    Mongelli, P.
    Liso, V.
    Specchia, G.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S266 - S267
  • [24] Antibacterial antibiotic exposures and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
    Zhang, Shijia
    Shanley, Ryan
    Rashidi, Armin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Comparison of hematopoietic recovery following allogeneic blood stem cell transplantation and allogeneic bone marrow transplantation.
    Bishop, MR
    Tarantolo, SR
    MartinAlgarra, S
    Cowles, K
    Bierman, PJ
    Vose, JM
    Reed, EC
    Gross, TG
    Armitage, JO
    Pavletic, ZS
    Nasrati, K
    Kessinger, A
    [J]. BLOOD, 1995, 86 (10) : 1553 - 1553
  • [26] Improving Safety of Preemptive Therapy with Oral Valganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Barkam, Corinna
    Kamal, Haytham
    Dammann, Elke
    Diedrich, Helmut
    Buchholz, Stefanie
    Eder, Matthias
    Krauter, Juergen
    Ganser, Arnold
    Stadler, Michael
    [J]. BONE MARROW RESEARCH, 2012,
  • [27] Valganciclovir is safe and effective as pre-emptive treatment for CMV infection in allogeneic hematopoietic stem cell transplantation.
    Pastano, Rocco
    Gigli, Federica
    Andreola, Giovanna
    Calabrese, Liliana
    Peccatori, Fedro
    Martinelli, Giovanni
    [J]. BLOOD, 2006, 108 (11) : 417B - 417B
  • [28] Prospective Study of Oral Valganciclovir for Pre-Emptive Therapy of Cytomegalovirius After Allogeneic Stem Cell Transplantation.
    De La Camara, Rafael
    Vazquez, Lourdes
    Lopez, Javier
    Solano, Carlos
    Serrano, David
    Gracia-Noblejas, Ana
    Ribera, Josep-Maria
    Ferra, Christelle
    [J]. BLOOD, 2009, 114 (22) : 479 - 480
  • [29] The natural history and control of cytomegalovirus infection following allogeneic stem cell transplantation
    Gamett, G.
    Boeckh, M.
    Einsele, H.
    Emery, V.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S237 - S238
  • [30] Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation
    Shafat, Manar S.
    Mehra, Vedika
    Peggs, Karl S.
    Roddie, Claire
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
12345